For in vitro diagnostic use. Others Elecsys beta-CrossLaps serum IVD Elecsys® β-CrossLaps/serum CPS_000446 09005773160 B-CrossLaps/serum Elecsys cobas e 100 V2 Elecsys beta-CrossLaps/serum 07613336187012 Reagents, kits 100 tests cobas e 411/601/602 true 09005773190 B-CrossLaps/serum Elecsys cobas e 100 V2 Elecsys beta-CrossLaps/serum 07613336171554 Reagents, kits 100 tests cobas e 411/601/602 true 09005781190 B-CrossLaps/serum Elecsys E2G 100 V2 Elecsys beta-CrossLaps/serum 07613336171561 Reagents, kits 100 tests cobas e 402/801 true 11972308122 B-CrossLaps/serum Elecsys cobas e 100 Elecsys beta-CrossLaps/serum 04015630914159 Reagents, kits 100 tests cobas e 411/601/602 true 07026960190 B-CrossLaps/serum Elecsys E2G 100 Elecsys beta-CrossLaps/serum 04015630940141 Reagents, kits 100 tests cobas e 402/801 true 11972308160 B-CrossLaps/serum Elecsys cobas e 100 Elecsys beta-CrossLaps/serum 04015630938902 Reagents, kits 100 tests cobas e 411/601/602 true 09005781214 B-CrossLaps/serum Elecsys E2G 100 V2 B-CrossLaps/serum Elecsys E2G 100 V2 07613336185681 Reagents, kits 100 tests cobas e 402/801 true 09005773501 Elecsys β-CrossLaps/serum en 1 FF00000004ED540E FF00000004ED540E 09005773190 09005773160 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of degradation products of type I collagen in human serum and plasma as an aid in assessing bone resorption. The test may be used as an aid in monitoring antiresorptive therapies in osteoporotic patients.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 09005773500 Elecsys β-CrossLaps/serum en 1 FF000000048BD90E FF000000048BD90E 09005773190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of degradation products of type I collagen in human serum and plasma as an aid in assessing bone resorption. The test may be used as an aid in monitoring antiresorptive therapies in osteoporotic patients.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 09005781500 Elecsys β-CrossLaps/serum en 2 FF000000059F970E FF000000048BDC0E 09005781190 09005781214 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of degradation products of type I collagen in human serum and plasma as an aid in assessing bone resorption. The test may be used as an aid in monitoring antiresorptive therapies in osteoporotic patients.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 09005781501 Elecsys β-CrossLaps/serum en 2 FF00000005318C0E FF00000004EB380E 09005781190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of degradation products of type I collagen in human serum and plasma as an aid in assessing bone resorption. The test may be used as an aid in monitoring antiresorptive therapies in osteoporotic patients.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 11972308500 Elecsys β-CrossLaps/serum en 18 FF000000048E0D0E FF00000000218B0E 11972308122 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of degradation products of type I collagen in human serum and plasma as an aid in assessing bone resorption. The test may be used as an aid in monitoring antiresorptive therapies in osteoporotic patients.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 07026960500 Elecsys β-CrossLaps/serum en 5 FF000000048E680E FF00000001A56F0E 07026960190 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of degradation products of type I collagen in human serum and plasma as an aid in assessing bone resorption. The test may be used as an aid in monitoring antiresorptive therapies in osteoporotic patients.The electrochemiluminescence immunoassay “ECLIA” is intended for use on the cobas e 801 immunoassay analyzer. en 07026960501 Elecsys β-CrossLaps/serum en 1 FF00000001DCB60E FF00000001DCB60E 07026960190 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of degradation products of type I collagen in human serum and plasma as an aid in assessing bone resorption. The test may be used as an aid in monitoring antiresorptive therapies (e.g. bisphosphonates, hormone replacement therapy - HRT) in postmenopausal women and individuals diagnosed with osteopenia.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en ms_11972308160_USA Elecsys β-CrossLaps/serum en 9 FF0000000308590E FF000000002E960E 11972308160 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of degradation products of type I collagen in human serum and plasma as an aid in assessing bone resorption. The test may be used as an aid in monitoring antiresorptive therapies (e.g. bisphosphonates, hormone replacement therapy - HRT) in postmenopausal women and individuals diagnosed with osteopenia.The electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers. en